Related Blog Posts
Dose of Reality: Beware of Clinics Touting Stem Cell Panaceas
19 hours ago ago from Magazine
Illustration: James Joyce Stem cells may be the key to a bright, shiny future of cure-all medicine. But we're not there yet. Biologists are still sorting out the basics of how to turn stem cells into regenerative therapies. Unfortunately, that hasn't stopped dozens of foreign clinics from offering stem cell treatments without much of a fight from regulators or the scientific community to any desperate patient who feels that mainstream ...
Related contentMinorities might not benefit from stem cell research.
20 hours ago ago from The Coozer Files
From BusinessWeek : Human embryonic stem cell lines currently used for research come mostly from white donors, a new report finds. That could mean that nonwhites will benefit less from any medical breakthroughs that emerge from that research down the line, experts say. Blacks could be especially affected. In fact, none of the most widely used stem cell lines studied showed any traces of recent African ancestry, the team reported online ...
Related contentVivakor’s Management Sees New Opportunities in Stem Cell Research
19 hours ago ago from SmallCapVoice.com
CORALVILLE, IA (Marketwire 12/21/09) Vivakor, Inc. (OTC.BB: VIVK ) With the recent authorization of 13 new stem lines by the National Institutes of Health and another 96 new lines awaiting federal approval, combined with the Obama administration's focus on funding research on these newly released stem cell lines (31 grants worth approximately $21 million have already been approved by the NIH), Vivakor and its biological handling division have ...
Related contentMost Stem Cells Used In Research Come From Whites
22 hours ago ago from THE B.S. REPORT
(Pic added by B.S. Report) (HealthDay News) Human embryonic stem cell lines currently used for research come mostly from white donors, a new report finds. That could mean that nonwhites will benefit less from any medical breakthroughs that emerge from that research down the line, experts say. Blacks could be especially affected. In fact, none of the most widely used stem cell lines studied showed any traces of recent African ...
Related contentTetrad HORRORS: Shot, Diabetes, Cecity, ALS you said it Embryonic Root Cell Research May Licking The
14 hours ago ago from vancewhitakerrf
& nbsp; & nbsp; 4 HORRORS: Shot, Diabetes, Cecity, ALSand How Embryonic Radical Cell Research May Licking Them By Don C Reed Before I encountered the monster on tour, I holded get on my mode South to City of the angels for the Fencesitter Citizens Inadvertence Commission ( ICOC ). This was an especially important meeting at which the large disease squad grants would be determined, equally very much like $ 20 million each, ...
Related contentRelated News
Pfizer Acquires a Stem-Cell Therapy
17 hours ago ago from The New York Times
Pfizer said Sunday that it was buying the rights to a somewhat controversial cell therapy from Athersys, a biotechnology company a sign of big pharmaceutical companies' growing interest in stem cells . Add to Portfolio Pfizer Inc Go to your Portfolio Pfizer will have the rights to develop Athersys's cells to treat inflammatory bowel disease , the companies are expected to announce on Monday. It will pay Athersys $6 ...
Related contentRelated Videos
Nothing to see... move along.
